Expert opinion on expanding anti-HBV treatment for chronic hepatitis B / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 131-136, 2022.
Artículo
en Chino
| WPRIM
| ID: wpr-928459
ABSTRACT
To meet the unmet medical needs and better reflect the new clinical evidence of chronic hepatitis B management, Chinese Society of Hepatology developed expert consensus on expanding diagnosis and treatment in China. The recommendations include to expand HBsAg screening in the population and HBV DNA detection by sensitive quantitative real-time PCR (qPCR), decrease the alanine aminotransferase (ALT) threshold for treatment of chronic hepatitis B, and promptly start antiviral therapy in the patients who are at risk of disease progression, and appropriately manage the patients with low level viremia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
ADN Viral
/
Hepatitis B Crónica
/
Alanina Transaminasa
/
Testimonio de Experto
/
Antígenos de Superficie de la Hepatitis B
Tipo de estudio:
Guía de Práctica Clínica
Límite:
Humanos
Idioma:
Chino
Revista:
Chinese Journal of Hepatology
Año:
2022
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS